The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model

International Journal of Oncology

Volumn 39, Issue 5, 2011, Pages 1337-1345

  Pons, Berta ^a,b   Peg, Vicente ^a   Vázquez Sánchez, María Ángeles ^a   López Vicente, Laura ^a   Argelaguet, Elisabet ^a   Coch, Laura ^a   Martínez, Alba ^a   Hernández Losa, Javier ^a   Armengol, Gemma ^a,b   Ramon Y Cajal, Santiago ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

catenin; 4E binding protein 1; Breast cancer; E cadherin; Eukaryotic initiation factor 4E; Protein translation

Indexed keywords

BETA CATENIN; CGP 57380; INITIATION FACTOR 4E; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MUTANT PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BREAST CARCINOMA; CANCER MODEL; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; GENE EXPRESSION; HUMANS; MICE; MICE, NUDE; MULTIPROTEIN COMPLEXES; MUTANT PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; SIGNAL TRANSDUCTION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80053207573     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1118     Document Type: Article

References (35)

1. Armengol G, Rojo F, Castellvi J, et al: 4E-binding protein 1: a key molecular funnel factor in human cancer with clinical implications. Cancer Res 67: 7551-7555, 2007. (Pubitemid 47281345)
2. Rojo F, Najera L, Lirola J, et al: 4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis. Clin Cancer Res 13: 81-89, 2007. (Pubitemid 46121856)
3. Castellvi J, Garcia A, Rojo F, et al: Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer. Cancer 107: 1801-1811, 2006. (Pubitemid 44582949)
4. Castellvi J, Garcia A, Ruiz-Marcellan C, et al: Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis. Hum Pathol 40: 1418-1426, 2009.
5. Graff JR, Konicek BW, Lynch RL, et al: eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival. Cancer Res 69: 3866-3873, 2009.
6. O'Reilly KE, Warycha M, Davies MA, et al: Phosphorylated 4E-BP1 is associated with poor survival in melanoma. Clin Cancer Res 15: 2872-2878, 2009.
7. Zhou X, Tan M, Stone Hawthorne V, et al: Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers. Clin Cancer Res 10: 6779-6788, 2004. (Pubitemid 39383026)
8. Kremer CL, Klein RR, Mendelson J, et al: Expression of mTOR signaling pathway markers in prostate cancer progression. Prostate 66: 1203-1212, 2006. (Pubitemid 44175342)
9. Avdulov S, Li S, Michalek V, et al: Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell 5: 553-563, 2004. (Pubitemid 38748917)
10. Mamane Y, Petroulakis E, LeBacquer O and Sonenberg N: mTOR, translation initiation and cancer. Oncogene 25: 6416-6422, 2006. (Pubitemid 44582285)
11. Schneider RJ and Sonenberg N: Translational control in cancer development and progression. In: Translational Control in Biology and Medicine. Mathews M, Sonenberg N and Hershey JWB (eds). Cold Spring Harbor Laboratory Press, New York, pp401-432, 2007.
12. Oridate N, Kim HJ, Xu X and Lotan R: Growth inhibition of head and neck squamous carcinoma cells by small interfering RNAs targeting eIF4E or cyclin D1 alone or combined with cisplatin. Cancer Biol Ther 4: 318-323, 2005. (Pubitemid 41351293)
13. Graff JR, Konicek BW, Vincent TM, et al: Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J Clin Invest 117: 2638-2648, 2007. (Pubitemid 47494364)
14. Richter JD and Sonenberg N: Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 433: 477-480, 2005. (Pubitemid 40204297)
15. Scheper GC and Proud CG: Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation? Eur J Biochem 269: 5350-5359, 2002. (Pubitemid 35365524)
16. Coleman LJ, Peter MB, Teall TJ, et al: Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity. Br J Cancer 100: 1393-1399, 2009.
17. Minich WB, Balasta ML, Goss DJ and Rhoads RE: Chromatographic resolution of in vivo phosphorylated and nonphosphorylated eukaryotic translation initiation factor eIF-4E: increased cap affinity of the phosphorylated form. Proc Natl Acad Sci USA 91: 7668-7672, 1994. (Pubitemid 24238246)
18. Wendel HG, Silva RL, Malina A, et al: Dissecting eIF4E action in tumorigenesis. Genes Dev 21: 3232-3237, 2007. (Pubitemid 350277750)
19. Chen YJ, Tan BC, Cheng YY, Chen JS and Lee SC: Differential regulation of CHOP translation by phosphorylated eIF4E under stress conditions. Nucleic Acids Res 38: 764-777, 2009.
20. Zuberek J, Wyslouch-Cieszynska A, Niedzwiecka A, et al: Phosphorylation of eIF4E attenuates its interaction with mRNA 5' cap analogs by electrostatic repulsion: intein-mediated protein ligation strategy to obtain phosphorylated protein. RNA 9: 52-61, 2003. (Pubitemid 36206302)
21. Constantinou C and Clemens MJ: Regulation of the phosphorylation and integrity of protein synthesis initiation factor eIF4GI and the translational repressor 4E-BP1 by p53. Oncogene 24: 4839-4850, 2005. (Pubitemid 41076302)
22. Yang DQ and Kastan MB: Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat Cell Biol 2: 893-898, 2000.
23. De Benedetti A and Harris AL: eIF4E expression in tumors: its possible role in progression of malignancies. Int J Biochem Cell Biol 31: 59-72, 1999. (Pubitemid 29094790)
24. De Benedetti A and Graff JR: eIF-4E expression and its role in malignancies and metastases. Oncogene 23: 3189-3199, 2004. (Pubitemid 38638830)
25. Ma XM and Blenis J: Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10: 307-318, 2009.
26. Ueda T, Watanabe-Fukunaga R, Fukuyama H, Nagata S and Fukunaga R: Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol Cell Biol 24: 6539-6549, 2004. (Pubitemid 38944335)
27. Lachance PE, Miron M, Raught B, Sonenberg N and Lasko P: Phosphorylation of eukaryotic translation initiation factor 4E is critical for growth. Mol Cell Biol 22: 1656-1663, 2002. (Pubitemid 34174983)
28. Topisirovic I, Ruiz-Gutierrez M and Borden KL: Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities. Cancer Res 64: 8639-8642, 2004. (Pubitemid 39552077)
29. Rousseau D, Kaspar R, Rosenwald I, Gehrke L and Sonenberg N: Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc Natl Acad Sci USA 93: 1065-1070, 1996. (Pubitemid 26054368)
30. Ruggero D, Montanaro L, Ma L, et al: The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med 10: 484-486, 2004. (Pubitemid 38667906)
31. Li BD, Gruner JS, Abreo F, et al: Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome. Ann Surg 235: 732-739, 2002. (Pubitemid 34454162)
32. Proud CG: Signalling to translation: how signal transduction pathways control the protein synthetic machinery. Biochem J 403: 217-234, 2007.
33. Buxade M, Parra JL, Rousseau S, et al: The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1. Immunity 23: 177-189, 2005. (Pubitemid 41169287)
34. Buxade M, Parra-Palau JL and Proud CG: The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases). Front Biosci 13: 5359-5373, 2008.
35. Niessen CM and Gottardi CJ: Molecular components of the adherens junction. Biochim Biophys Acta 1778: 562-571, 2008.